<div>* Low &lt;3000₺; intermediate 3000 – 5000 ₺; High &gt;
5000 ₺</div><div><i>T. gondii</i> IgG antibodies were found statistically higher in 63
(53.8%) of the 117 patients with schizophrenia and in 33 (27.5%) of
the 120 controls (p &lt; 0.001). When the cases included in the
schizophrenia group are examined by dividing into two sub-groups
according to their suicide attempt history, the relationship between the
history of suicide attempt and seroprevalence <i>T. gondii</i> was again
found to be statistically significant (p &lt; 0.05). In
reflection of our serological findings, it was determined that the rates
of <i>T. gondii</i> seropositivity were higher in the schizophrenia
group, compared to the control group. Likewise, <i>T. gondii</i> IgG
antibodies positivity was found to be more in schizophrenia patients
with a history of suicide attempt (Table 3).</div><div>The results in Table 3 also summarized that the molecular detection of<i>T. gondii</i> by PCR. The molecular positivity rate of T. gondii was
higher in schizophrenia group, compared to healthy control group (p
&lt; 0.05), whereas history of suicide attempts was not
statistically associated (p = 0.831) with <i>T. gondii</i> positivity by
PCR (Table 3). This could be attributed to the fact that the <i>T.
gondii</i> is less detected by the molecular method than the serological
method. In this study, the amplified products were visualized by the
standard gel electrophoresis and Figure 2 shows a sample image of
electrophoresis.</div><div><b>Table 3.</b> Comparison between schizophrenia and control group for<i>T. gondii</i> status</div>